ASTS
AST SpaceMobile, Inc.
ASTS offers stronger modeled upside, but that advantage does not outweigh its weaker overall profile.
OTEX
Open Text Corporation
OTEX has the edge over ASTS overall, supported by stronger valuation and lower modeled downside.
ASTS Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Weak | |
| Weak | |
| Unavailable |
ASTS's revenue is currently healthy, but its profitability and cash flow are weak. There isn't enough data to rate its balance sheet.
OTEX Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Strong | |
| Healthy | |
| Under pressure |
OTEX's profitability and cash flow are currently healthy, and its revenue is stable, but its balance sheet is under pressure.
ASTS PE Valuation
ASTS has no meaningful PE right now: it lost money over the past year.
OTEX PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 6.4x | $24.81 | — |
| Current | 9.4x | $24.81 | — |
| Cheap | 14x | $35.71 | +44% |
| Fair | 31x | $83.11 | +235% |
| Expensive | 53x | $139 | +462% |
Historical ranges are pointers, not guarantees.
OTEX's PE is in its cheap range at 9.4x. On analysts' estimates for next year's earnings, today's price would be 6.4x.
ASTS Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses growing | |
| Strong growth | |
| -- | |
| Limited | |
| Low |
Analysts expect ASTS's losses to grow, with revenue growing. However, they disagree widely on these estimates.
OTEX Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Stable | |
| Stable | |
| Weakening | |
| Limited | |
| High |
Analysts expect OTEX's profitability to weaken, with its earnings and revenue holding steady.
ASTS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$2.15 | -$0.91 |
| Q2 2026 | -$2.16 | -$0.27 |
| Q1 2026 | -$1.80 | +$0.19 |
| Q4 2025 | -$1.34 | +$0.61 |
| Q3 2025 | -$1.24 | +$0.88 |
| Q2 2025 | -$1.89 | -$0.64 |
| Q1 2025 | -$1.99 | -$1.01 |
| Q4 2022 | -$0.58 | -$0.21 |
ASTS is still losing money, but far less than before: $2.15 per share over the past year, against $5.76 at its worst in mid-2021.
OTEX Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $3.86 | +46% |
| Q3 2026 | $2.64 | +38% |
| Q2 2026 | $2.58 | +56% |
| Q1 2026 | $2.05 | -16% |
| Q4 2025 | $1.70 | -31% |
| Q3 2025 | $1.91 | +10% |
| Q2 2025 | $1.65 | -3.5% |
| Q1 2025 | $2.45 | +295% |
| Q4 2024 | $2.46 | +423% |
OTEX has the edge over ASTS on earnings quality, reporting a profit while its opponent remains loss making.
ASTS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $42.3M | +187% |
| Q2 2026 | $31.5M | +2627% |
| Q1 2026 | $14.7M | +1952% |
| Q4 2025 | $54.3M | +2731% |
| Q3 2025 | $14.7M | +1240% |
| Q2 2025 | $1.2M | +28% |
| Q1 2025 | $718K | +44% |
| Q3 2022 | $4.2M | +70% |
ASTS has the edge over OTEX on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -415% | +694 points |
| Q2 2026 | -948% | +10744 points |
| Q1 2026 | -1686% | +7083 points |
| Q4 2025 | -175% | +2446 points |
| Q3 2025 | -1109% | +4850 points |
| Q2 2025 | -11692% | -4693 points |
| Q1 2025 | -8769% | +2331 points |
| Q4 2024 | -2621% | N/A |
ASTS's operating margin was −415% last quarter, up 694 points from the same quarter a year ago.
OTEX Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $1.2B | -4% |
| Q2 2026 | $1.3B | +2.9% |
| Q1 2026 | $1.3B | +2.2% |
| Q4 2025 | $1.3B | -0.6% |
| Q3 2025 | $1.3B | +1.5% |
| Q2 2025 | $1.3B | -3.8% |
| Q1 2025 | $1.3B | -13% |
| Q4 2024 | $1.3B | -13% |
OTEX's revenue fell from its 2023 peak and has held roughly level since: $1.2B last quarter, down 4% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 20% | -0.7 points |
| Q2 2026 | 24% | +9.8 points |
| Q1 2026 | 16% | -1 points |
| Q4 2025 | 22% | -0.2 points |
| Q3 2025 | 21% | +4.7 points |
| Q2 2025 | 14% | -0.3 points |
| Q1 2025 | 17% | +1 points |
| Q4 2024 | 22% | +5.6 points |
OTEX has the edge over ASTS on profitability, with a higher operating margin.
ASTS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$464.2M | -$161.4M |
| Q2 2026 | -$694.8M | -$341.1M |
| Q1 2026 | -$309.7M | -$160.7M |
| Q4 2025 | -$330.7M | -$220.3M |
| Q3 2025 | -$302.9M | -$239.1M |
| Q2 2025 | -$353.6M | -$315.3M |
| Q1 2025 | -$149M | -$61.3M |
| Q4 2024 | -$110.5M | -$63.2M |
ASTS has burned cash in almost every quarter: −$1.8B over the past year, against −$916M the year before.
OTEX Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $138.5M | +37% |
| Q2 2026 | $122M | -1.6% |
| Q1 2026 | $304.9M | -18% |
| Q4 2025 | $279.4M | -8.9% |
| Q3 2025 | $101.2M | +$218.4M |
| Q2 2025 | $124M | -15% |
| Q1 2025 | $373.8M | +7.4% |
| Q4 2024 | $306.7M | +0.4% |
OTEX has the edge over ASTS on cash generation, producing positive trailing cash flow while its opponent burns cash.
ASTS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.4% | +1.1M shares |
| 1 year | +10% | +27.3M shares |
| 3 years | +235% | +211M shares |
| 5 years | +480% | +248M shares |
| Available history | +944% | +271M shares |
ASTS has 300M diluted shares, up 10% from a year ago.
| Quarter | Spent |
|---|---|
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
| Q2 2024 | — |
| Q1 2024 | — |
| Q4 2023 | — |
| Q3 2023 | — |
| Q2 2023 | — |
OTEX Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -2.9% | -7.3M shares |
| 1 year | -4.6% | -11.7M shares |
| 3 years | -11% | -29.8M shares |
| 5 years | -11% | -31.1M shares |
| Available history | -11% | -29.5M shares |
OTEX has the edge over ASTS on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $30M |
| Q2 2026 | $11.8M |
| Q1 2026 | $247M |
| Q4 2025 | $50M |
| Q3 2025 | $107.6M |
| Q2 2025 | $145.3M |
| Q1 2025 | $114.6M |
| Q4 2024 | $66M |
OTEX spent $339M buying back its own shares over the past year, down 22% from the year before.
ASTS Net Leverage
ASTS's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
OTEX Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 3.2x | Elevated |
| Q2 2026 | 3.2x | Elevated |
| Q1 2026 | 3.6x | Elevated |
| Q4 2025 | 3.6x | Elevated |
| Q3 2025 | 3.8x | Elevated |
| Q2 2025 | 3.9x | Elevated |
| Q1 2025 | 3.7x | Elevated |
| Q4 2024 | 3.7x | Elevated |
OTEX's net debt is about 3.2 years of its operating earnings (EBITDA), down from 3.8 years a year ago.
ASTS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 34.1 | Neutral |
| Stochastic | 11.9 | Oversold |
ASTS's weekly RSI is 34 (neutral) and its Stochastic is 12 (oversold).
OTEX Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 50.9 | Neutral |
| Stochastic | 57.4 | Neutral |
OTEX's weekly RSI is 51 (neutral) and its Stochastic is 57 (neutral).
ASTS PE vs Technology Sector
ASTS has no meaningful PE right now: it lost money over the past year.
OTEX PE vs Technology Sector
| Metric | OTEX | Sector median | Relative |
|---|---|---|---|
| PE | 9.4x | 28x | 66% below |
| PE % | 2 | 35 | 33 pts below |
OTEX is trading at 9.4x earnings, a 66% discount to the Technology sector's median of 28x.
ASTS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $44.9 | 23% below |
| 20 week MA | $57.1 | 40% below |
| 50 week MA | $75.5 | 54% below |
| 100 week MA | $57.8 | 40% below |
| 200 week MA | $33.6 | 2.8% above |
ASTS has fallen below most of its moving averages, though it's still 2.8% above its 200-week average.
OTEX Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $24.8 | 0.2% above |
| 20 week MA | $24.2 | 2.5% above |
| 50 week MA | $25.1 | 1.1% below |
| 100 week MA | $27.6 | 10% below |
| 200 week MA | $31.8 | 22% below |
OTEX has the edge over ASTS on trend strength, trading above more of its moving averages.
ASTS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $9.87 | $13.4 | +36% |
| 2021 | $13.4 | $8.71 | -35% |
| 2022 | $8.71 | $3.97 | -54% |
| 2023 | $3.97 | $6.03 | +52% |
| 2024 | $6.03 | $22.9 | +280% |
| 2025 | $22.9 | $72.0 | +214% |
| 2026 YTD | $72.0 | $34.5 | -52% |
ASTS's yearly returns have swung widely, from +280% in 2024 to −54% in 2022. It's down 52% so far in 2026.
OTEX Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $44.1 | $45.7 | +3.8% |
| 2021 | $45.7 | $47.4 | +3.6% |
| 2022 | $47.4 | $29.0 | -39% |
| 2023 | $29.0 | $42.0 | +45% |
| 2024 | $42.0 | $28.3 | -33% |
| 2025 | $28.3 | $33.5 | +18% |
| 2026 YTD | $33.5 | $24.8 | -26% |
OTEX has the edge over ASTS on returns for 2026, with the stronger performance.